NDC 37662-1626

Terebinthina

Terebinthina

Terebinthina is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Turpentine Oil.

Product ID37662-1626_e9c4851b-1216-3272-e053-2995a90a64a3
NDC37662-1626
Product TypeHuman Otc Drug
Proprietary NameTerebinthina
Generic NameTerebinthina
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-09-28
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NameTURPENTINE OIL
Active Ingredient Strength200 [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 37662-1626-1

200 PELLET in 1 VIAL, GLASS (37662-1626-1)
Marketing Start Date2022-09-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Terebinthina" or generic name "Terebinthina"

NDCBrand NameGeneric Name
0220-4957TerebinthinaTURPENTINE OIL
0220-4958TerebinthinaTURPENTINE OIL
15631-0434TEREBINTHINATEREBINTHINA
37662-1622TerebinthinaTerebinthina
37662-1623TerebinthinaTerebinthina
37662-1624TerebinthinaTerebinthina
37662-1625TerebinthinaTerebinthina
37662-1626TerebinthinaTerebinthina
37662-1627TerebinthinaTerebinthina
37662-1628TerebinthinaTerebinthina
37662-1629TerebinthinaTerebinthina
68428-668TerebinthinaTURPENTINE
71919-669TEREBINTHINATurpentine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.